Medicaid Rebates For Brands Could Rise $3.2Bn Over Next Decade Under New Law

Provision included in appropriations legislation directs manufacturers to calculate average prices for brands without including the cost of authorized generics, which will lead to higher rebates.

Rebates_535538281_1200.jpg
Authorized Generics Curbed Medicaid Rebates By 46% In OIG Analysis

More from Pricing Debate

More from Market Access